Lexaria Bioscience Corp.
About Lexaria Bioscience Corp.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 3500000 MR: - FA: approximately $3.5 million FAN: 3500000 |
D: 2025-12-16 FD: 2025-12-16 |
1 investors |
| 2 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 3500000 MR: - FA: $3.5 million FAN: 3500000 |
D: 2025-12-15 FD: 2025-12-15 |
1 investors |
| 3 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 4000000 MR: - FA: $4.0 million FAN: 4000000 |
D: 2025-09-29 FD: 2025-09-29 |
- |
| 4 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 4000000 MR: - FA: 4.0 million FAN: 4000000 |
D: 2025-09-26 FD: 2025-09-26 |
1 investors |
| 5 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 2000000 MR: - FA: $2 Million FAN: 2000000 |
D: 2025-04-28 FD: 2025-04-28 |
1 investors |
| 6 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 2000000 MR: - FA: $2 million FAN: 2000000 |
D: 2025-04-25 FD: 2025-04-25 |
1 investors |
| 7 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 5000000 MR: - FA: approximately $5 million FAN: 5000000 |
D: 2024-10-16 FD: 2024-10-16 |
1 investors |
| 8 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 5000000 MR: - FA: approximately $5 million FAN: 5000000 |
D: 2024-10-15 FD: 2024-10-15 |
1 investors |
| 9 |
RT: Warrant Exercise and Private Placement T: - FT: Warrant Exercise and Private Placement |
A: 4700000 MR: - FA: 4.7 million FAN: 4700000 |
D: 2024-04-30 FD: 2024-04-30 |
2 investors |
| 10 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 3600000 MR: - FA: approximately $3.6 million FAN: 3600000 |
D: 2024-02-16 FD: 2024-02-16 |
1 investors |
| 11 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 3600000 MR: - FA: $3.6 million FAN: 3600000 |
D: 2024-02-15 FD: 2024-02-15 |
- |
| 12 |
RT: Registered Direct Offering and Concurrent Private Placement T: - FT: Registered Direct Offering and Concurrent Private Placement |
A: 1600000 MR: - FA: $1.6 million FAN: 1600000 |
D: 2023-09-29 FD: 2023-09-29 |
1 investors |
| 13 |
RT: Public Offering T: - FT: Public Offering |
A: 2000000 MR: - FA: 2.0 million FAN: 2000000 |
D: 2023-05-11 FD: 2023-05-11 |
- |
| 14 |
RT: Public Offering T: - FT: Public Offering |
A: 2000000 MR: - FA: 2.0 Million FAN: 2000000 |
D: 2023-05-08 FD: 2023-05-08 |
- |
Growth Metrics
Team & Leadership
Richard Christopher
CEO
John Docherty
Chairman
Michael Shankman
CFO
Chris Bunka
Executive Strategic Advisor
Bal Bhullar
CFO and Director
Nicholas Baxter
Member of the Board of Directors
Recent News
Lexaria Bioscience Corp. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- lexariabioscience.com
- Industries
- Biotechnology / Pharmaceuticals
- Company Size
- ~340 employees (est.)
- Locations
-
KELOWNA, BRITISH COLUMBIA
KELOWNA, BC
Kelowna, BC, Canada +1 more
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro